UK Therapeutic Cancer Prevention Network Group
Bringing together a unique blend of research expertise in cancer chemoprevention including scientists, clinicians, epidemiologists, statisticians and specialists in primary care, diet and nutrition.
Scope of membership
Clinical and non-clinical researchers across the UK who have an interest and demonstrated research activity in a relevant subject area are welcome to join.
Ordinary membership of the UK Therapeutic Cancer Network (UKTCPN) is available to researchers at all stages of their career.
Membership is also open to members of organisations such as cancer charities, and to patients or members of the public who have an interest in this field.
Remit
Establish a network of clinical and non-clinical researchers with a variety of scientific backgrounds across the UK.
Identify areas of strength in the field among research groups across the UK and disseminate this information to facilitate collaboration.
Provide infrastructure to organise scientific meetings focusing on therapeutic or dietary interventions for cancer prevention.
Increase awareness of the field amongst the cancer research community, governmental organisations and funding bodies.
Become widely accepted as the focus of expertise in cancer chemoprevention and other therapeutic interventions to prevent cancer.
Become a champion for increased research funding in the field of therapeutic cancer prevention.
Provide collaboration among investigators and develop joint grant applications, building on complementary strengths across the network.
Promote the translation of pre-clinical research findings into clinical trials of cancer prevention.
Provide guidance and support in the development of clinical trials protocols for interventional cancer prevention studies.
Steering committee
Karen Brown, Leicester Experimental Cancer Medicine Centre (ECMC) (Co-chair)
Ruth Langley, University College London ECMC (Co-chair)
Sylvia Bailey, West Midlands
Emma Vincent, University of Bristol
Sam Orange, Newcastle ECMC
Caroline McCarthy, Liverpool ECMC
James Reading, University College London ECMC
James Flanagan, Imperial College London ECMC
Vicky Coyle, Belfast ECMC
Farhat Din, Edinburgh ECMC
Albena Dinkova-Kostova, University of Dundee
Gareth Evans, Manchester ECMC
Mark Hull, University of Leeds
Farhat Khanim, Birmingham ECMC
Mangesh Thorat, Barts ECMC
Mieke Van Hemelrijck, King's Health Partners ECMC
You might also be interested in
Latest news
Explore the latest articles, updates, interviews and news from our network.
Patients and public
We support patient-centric early-phase trials. Patient and public involvement shapes everything we do.
Sign up to our newsletter
Be the first to hear about the latest network news, events and opportunities with our monthly newsletter.